Global Biosimilars Market by Manufacturers, Regions, Type and Application, Forecast to 2021

A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product which is almost an identical copy of an original product that is manufactured by a different company.

Published by: GIR (GlobalInfoResearch)

Catalog: Pharmaceutical

Publishing Date: Oct 2016

Single User License: USD 3480

Corporate Users License: USD 4680

Delivery time: 24 hours

Pages: 115

Tables and Figures: 138

Full information ：[url]http://www.globalinforesearch.com/goods.php?id=1220[url]

Scope of the Report:

This report focuses on the Biosimilars in Global market, especially in North America, Europe and Asia-Pacific, Latin America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Sandoz International

Hospira

Teva Pharmaceutical

Dr. Reddy’s Laboratories

Biocon

Mylan

Amgen

Celltrion

Roche Diagnostics?

Merck KGaA

Market Segment by Regions, regional analysis covers

North America (USA, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

Latin America, Middle East and Africa

Market Segment by Type, covers

Injection

Tablets

Others

Market Segment by Applications, can be divided into

Ankylosing Spondylitis

Tumor

Rheumatoid Arthrtis

Cardiovascular

There are 13 Chapters to deeply display the global Biosimilars market.

Chapter 1, to describe Biosimilars Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Biosimilars, with sales, revenue, and price of Biosimilars, in 2015 and 2016;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2015 and 2016;

Chapter 4, to show the global market by...